121765 Sigma-AldrichAG 825 - CAS 149092-50-2 - Calbiochem
A potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER2 (neu/ErbB2; IC₅₀ = 0.35 µM) relative to HER1 (IC₅₀= 19 µM) autophosphorylation.
More>> A potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER2 (neu/ErbB2; IC₅₀ = 0.35 µM) relative to HER1 (IC₅₀= 19 µM) autophosphorylation. Less<<Synonyme: 4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidenecyanoacetamide
Empfohlene Produkte
Übersicht
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
149092-50-2 | C₁₉H₁₅N₃O₃S₂ |
Preis & Verfügbarkeit
Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
---|---|---|---|---|---|---|
121765-2MG |
|
Kst.-Ampulle | 2 mg |
|
— |
Product Information | |
---|---|
CAS number | 149092-50-2 |
ATP Competitive | N |
Form | Yellow solid |
Hill Formula | C₁₉H₁₅N₃O₃S₂ |
Chemical formula | C₁₉H₁₅N₃O₃S₂ |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | HER2 |
Primary Target IC<sub>50</sub> | 0.35 µM against HER2 |
Purity | ≥94% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Bestellnummer | GTIN |
121765-2MG | 07790788047917 |
Documentation
AG 825 - CAS 149092-50-2 - Calbiochem SDB
Titel |
---|
AG 825 - CAS 149092-50-2 - Calbiochem Analysenzertifikate
Titel | Chargennummer |
---|---|
121765 |
Literatur
Übersicht |
---|
Ashton, J.M., et al. 2012. Cell Stem Cell 11, 359. Tsai, C.M., et al. 1996. Cancer Res. 56, 1068. Levitzki, A., and Gazit, A. 1995. Science 267, 1782. Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134. |